This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com
Early detection of Alzheimer's disease is crucial, and accessible diagnostic tools like retinal imaging are becoming increasingly vital.
In this episode, Eliav Shaked, co-founder of RetiSpec, discusses their innovative approach to early and accurate Alzheimer's detection using retinal imaging and artificial intelligence. RetiSpec focuses on identifying the core pathology of Alzheimer's, specifically amyloid burden, through a simple eye examination that can be incorporated into annual checkups. The company is also working on other neurodegenerative diseases beyond Alzheimer's. Eliav emphasizes the significance of recent breakthroughs in Alzheimer's medication, highlighting the potential of disease-modifying drugs now available, along with the growing innovation and therapeutic development in the space. He also predicts that more drugs will be developed for earlier stages of the disease and that technology will revolutionize healthcare.
Tune in and learn how this innovative technology is paving the way for better Alzheimer's care!
Resources:
Fast Track Your Business Growth:
Outcomes Rocket is a full-service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com
